BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 22975773)

  • 1. [CD20-positive peripheral T-cell lymphoma, not otherwise specified].
    Arai H; Maki K; Tadokoro J; Handa T; Nakamura Y; Tsurumi S; Sasaki K; Mitani K
    Rinsho Ketsueki; 2012 Jul; 53(7):705-9. PubMed ID: 22975773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Composite diffuse large B-cell lymphoma and CD20-positive peripheral T-cell lymphoma.
    Yamazaki S; Fujioka Y; Nakamura F; Ota S; Shinozaki A; Yamamoto G; Kamikubo Y; Nannya Y; Ichikawa M; Fukayama M; Kurokawa M
    Pathol Int; 2011 Nov; 61(11):662-6. PubMed ID: 22029677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extranodal CD20-positive peripheral T-cell lymphoma presenting with adrenal and testicular masses.
    Makita M; Murakami I; Yoshioka T; Tanaka H; Yamamoto K; Imajo K; Takata K; Yoshino T
    Rinsho Ketsueki; 2009 May; 50(5):413-8. PubMed ID: 19483402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD20-positive primary gastric T-cell lymphoma poorly responding to initial treatment with rituximab plus CHOP, and a literature review.
    Kakinoki Y; Hashiguchi J; Ishio T; Chiba K; Niino D; Ohshima K
    Int J Hematol; 2015 Dec; 102(6):702-8. PubMed ID: 26251099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CHOP or THP-COP regimens in the treatment of newly diagnosed peripheral T-cell lymphoma, not otherwise specified: a comparison of doxorubicin and pirarubicin.
    Shibata Y; Hara T; Kasahara S; Yamada T; Sawada M; Mabuchi R; Matsumoto T; Nakamura N; Nakamura H; Ninomiya S; Kitagawa J; Kanemura N; Kito Y; Goto N; Miyazaki T; Takami T; Takeuchi T; Shimizu M; Tsurumi H
    Hematol Oncol; 2017 Jun; 35(2):163-171. PubMed ID: 26449182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Composite Lymphoma as Co-occurrence of Advanced Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Carrying Trisomy 12 and t(14;18) and Peripheral T-cell Lymphoma.
    Aoyama Y; Kodaka T; Zushi Y; Goto Y; Tsunemine H; Itoh T; Takahashi T
    J Clin Exp Hematop; 2018 Mar; 58(1):27-31. PubMed ID: 29415977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical outcomes of patients with peripheral T-cell lymphoma (PTCL) treated by EPOCH regimen].
    Peng YL; Huang HQ; Lin XB; Xia ZJ; Li YH; Wang W; He YJ; Pan ZH; Jiang WQ; Guan ZZ
    Ai Zheng; 2004 Aug; 23(8):943-6. PubMed ID: 15301720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary breast peripheral T-cell lymphoma not otherwise specified: report of a case.
    Muroya D; Toh U; Iwakuma N; Nakagawa S; Mishima M; Takahashi R; Takenaka M; Shirouzu K; Agaki Y
    Surg Today; 2015 Jan; 45(1):115-20. PubMed ID: 24395027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Small cell variant of peripheral T-cell lymphoma, not otherwise specified: a clinicopathologic and immunophenotypic analysis].
    Li YL; Liu WP; Tang Y; Zhao S; Zuo Z; Yang YH; Yang QP; Luo TY
    Zhonghua Bing Li Xue Za Zhi; 2009 May; 38(5):323-8. PubMed ID: 19575875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biweekly THP-COP therapy for newly diagnosed peripheral T-cell lymphoma patients.
    Tomita N; Kodama F; Tsuyama N; Sakata S; Takeuchi K; Ishibashi D; Koyama S; Ishii Y; Yamamoto W; Takasaki H; Hagihara M; Kuwabara H; Tanaka M; Hashimoto C; Yamazaki E; Koharazawa H; Fujimaki K; Sakai R; Fujisawa S; Ishigatsubo Y
    Hematol Oncol; 2015 Mar; 33(1):9-14. PubMed ID: 24519501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase II study of rituximab combined with pirarubicin-cyclophosphamide, vincristine and prednisolone regimen as first-line therapy for patients with indolent B-cell lymphoma.
    Tsurumi H; Hara T; Goto N; Kitagawa J; Kanemura N; Yoshikawa T; Kasahara S; Goto H; Fukuno K; Yamada T; Sawada M; Shimizu M; Takahashi T; Takami T; Moriwaki H
    Leuk Lymphoma; 2012 Feb; 53(2):247-53. PubMed ID: 21827339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicentre phase II study of the CyclOBEAP regimen for patients with peripheral T-cell lymphoma with analysis of biomarkers.
    Niitsu N; Hayama M; Yoshino T; Nakamura S; Tamaru J; Nakamine H; Okamoto M
    Br J Haematol; 2011 Jun; 153(5):582-8. PubMed ID: 21492124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD20-Positive peripheral T-cell lymphoma: report of a case after nodular sclerosis Hodgkin's disease and review of the literature.
    Mohrmann RL; Arber DA
    Mod Pathol; 2000 Nov; 13(11):1244-52. PubMed ID: 11106083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follicular peripheral T-cell lymphoma expands the spectrum of classical Hodgkin lymphoma mimics.
    Moroch J; Copie-Bergman C; de Leval L; Plonquet A; Martin-Garcia N; Delfau-Larue MH; Molinier-Frenkel V; Belhadj K; Haioun C; Audouin J; Swerdlow SH; Marafioti T; Gaulard P
    Am J Surg Pathol; 2012 Nov; 36(11):1636-46. PubMed ID: 23073322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of CHOP with THP-COP for peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma: a retrospective analysis using data from the population-based Osaka Cancer Registry.
    Kida S; Fuji S; Morishima T; Nakata K; Miyashiro I; Ishikawa J
    Int J Hematol; 2021 Aug; 114(2):246-251. PubMed ID: 33864237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of CD20 levels with clinicopathological parameters and its prognostic significance for patients with DLBCL.
    Suzuki Y; Yoshida T; Wang G; Togano T; Miyamoto S; Miyazaki K; Iwabuchi K; Nakayama M; Horie R; Niitsu N; Sato Y; Nakamura N
    Ann Hematol; 2012 Jul; 91(7):997-1005. PubMed ID: 22249209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral T-cell lymphoma--not otherwise specified.
    Savage KJ; Ferreri AJ; Zinzani PL; Pileri SA
    Crit Rev Oncol Hematol; 2011 Sep; 79(3):321-9. PubMed ID: 20702104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic Molecule-positive Epstein-Barr Virus-associated Peripheral T-cell Lymphoma in a 20-Month-old Child: A Case Report and Review of the Literature.
    Zhang H; Kheradpour A; Rowsell EH; Zuppan CW; Weiss LM; Wang J
    J Pediatr Hematol Oncol; 2015 Nov; 37(8):e475-80. PubMed ID: 26056791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sub-acute demyelinating polyradiculoneuropathy as an initial symptom of peripheral T cell lymphoma, not otherwise specified (PTCL-NOS).
    Kawanishi K; Ohyama Y; Kanai Y; Hirase T; Tanaka H; Miyatake J; Tatsumi Y; Ashida T; Nakamine H; Matsumura I
    Intern Med; 2012; 51(15):2015-20. PubMed ID: 22864129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral T cell lymphoma, not otherwise specified with myelofibrosis: report of a case with review of the literature.
    Sekiguchi Y; Shirane S; Shimada A; Ichikawa K; Wakabayashi M; Sugimoto K; Tomita S; Izumi H; Nakamura N; Sawada T; Ohta Y; Komatsu N; Noguchi M
    Int J Clin Exp Pathol; 2015; 8(4):4186-203. PubMed ID: 26097612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.